Northern Trust
CLDI icon

Northern Trust’s Calidi Biotherapeutics CLDI Stock Holding History

Northern Trust’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02K Hold
1,110
– – ﹤0.01% 4439
2026
Q1 		$4.24K Hold
1,110
– – ﹤0.01% 4392
2025
Q4 		$20.8K Buy
+1,110
New +$26.1K ﹤0.01% 4390
2025
Q3 		– Sell
-254
Closed -$11.2K – 4449
2025
Q2 		$11.2K Hold
254
– – ﹤0.01% 4370
2025
Q1 		$27.6K Buy
254
+150
+144% +$27.4K ﹤0.01% 4304
2024
Q4 		$22.9K Buy
+104
New +$31.2K ﹤0.01% 4363

Other funds holding CLDI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $533M AUM 20.75% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust's CLDI Position: Q2 2026 in Review

Northern Trust held its Calidi Biotherapeutics (CLDI) position steady in Q2 2026 at 1,110 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4439.

Northern Trust first reported a position in CLDI in Q4 2024 and has held it in 6 quarters since. The position peaked at $27.6K in Q1 2025. 22 funds tracked by Wall St. Rank hold CLDI as of Q2 2026.

  • Northern Trust held 1,110 shares of Calidi Biotherapeutics worth $3.02K as of Q2 2026.
  • Northern Trust left its Calidi Biotherapeutics share count unchanged in Q2 2026.
  • Calidi Biotherapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4439 holding.
  • Northern Trust first reported a position in Calidi Biotherapeutics in Q4 2024 and has held it in 6 quarters since.
  • Northern Trust's Calidi Biotherapeutics position peaked at $27.6K in Q1 2025.
  • 22 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.